생명과학 기기 시장 - 예측(2025-2030년)

The Life Science Instrumentation Market is projected to surge from USD 66.541 billion in 2025 to USD 89.679 billion by 2030, at a CAGR of 6.15%.

The life science instrumentation market is experiencing robust growth, driven by its critical role in advancing research, diagnostics, and industrial applications across biotechnology, pharmaceuticals, food and beverage, and environmental monitoring. These instruments enable cutting-edge innovations, improve treatment outcomes, and support quality control in manufacturing processes. Key drivers include increased pharmaceutical investments in drug discovery, rising infectious disease prevalence, and growing consumer health awareness in the food and beverage sector. Additionally, the expanding proteomics market and heightened environmental concerns are bolstering demand for advanced instrumentation.

Market Drivers

The pharmaceutical industry's focus on drug discovery and development is a primary growth driver, as life science instruments are integral to these processes. The rising incidence of infectious diseases has further amplified demand for diagnostic tools, particularly in clinical settings. In the food and beverage industry, growing consumer awareness of health and safety standards has spurred the adoption of instrumentation for quality assurance and testing. The proteomics market, which relies heavily on precise analytical tools, is also contributing to market expansion. Moreover, increasing environmental concerns have driven the use of instrumentation for monitoring and testing, ensuring compliance with regulatory standards. Sustained research and development efforts by key market players are expected to further propel market growth in the coming years.

Market Segmentation

The life science instrumentation market is segmented by technology, application, end-user, and geography. By technology, the market includes spectroscopy, chromatography, flow cytometry, and other advanced methods, each catering to specific analytical needs. By application, the market covers analytical chemistry, clinical analysis, environmental testing, food and beverage analysis, and other specialized areas, reflecting the diverse utility of these instruments. End-users include hospitals, research institutes, diagnostic laboratories, and other facilities, with each sector leveraging instrumentation for diagnostics, research, or quality control. This segmentation highlights the market's versatility across scientific and industrial domains.

Geographic Insights

While specific geographic trends are not detailed, the global nature of the market suggests strong growth in regions with robust pharmaceutical, biotechnology, and food industries. Developing economies with increasing healthcare and environmental investments are likely to contribute significantly to market expansion, alongside established markets with advanced research infrastructures.

Key Developments (2023-2025)

Notable advancements include Bruker Corporation's launch of the INVENIO X Fourier Transform Infrared system, designed for advanced molecular spectroscopy research. Additionally, Bio-Rad Laboratories Inc. introduced the BioPlex 2200 Lyme Total Assay, a US FDA-cleared platform aiding in the diagnosis of Lyme disease, enhancing diagnostic precision in clinical settings.

Key Players

Leading companies such as Bruker Corporation and Bio-Rad Laboratories Inc. are driving innovation through advanced product offerings and strategic R&D investments. These players are strengthening their market positions by addressing the growing demand for precise, reliable instrumentation across diverse applications.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Technology

• Spectroscopy
• Chromatography
• Flow Cytometry
• Others

By Application

• Analytical Chemistry
• Clinical Analysis
• Environmental Testing
• Food and Beverage Analysis
• Others

By End-Users

• Hospitals
• Research Institutes
• Diagnostic Laboratories
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LIFE SCIENCE INSTRUMENTATION MARKET BY TECHNOLOGY

• 5.1. Introduction
• 5.2. Spectroscopy
• 5.3. Chromatography
• 5.4. Flow Cytometry
• 5.5. Others

6. LIFE SCIENCE INSTRUMENTATION MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Analytical Chemistry
• 6.3. Clinical Analysis
• 6.4. Environmental Testing
• 6.5. Food and Beverage Analysis
• 6.6. Others

7. LIFE SCIENCE INSTRUMENTATION MARKET BY END-USERS

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Research Institutes
• 7.4. Diagnostic Laboratories
• 7.5. Others

8. LIFE SCIENCE INSTRUMENTATION MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Shimadzu Corporation
• 10.2. Bio-Rad Laboratories, Inc.
• 10.3. Becton, Dickinson and Company
• 10.4. PerkinElmer, Inc.
• 10.5. Danaher Corporation
• 10.6. Hitachi High-Technologies Corporation
• 10.7. Thermo Fisher Scientific Inc.
• 10.8. Bruker Corporation
• 10.9. General Electric Company

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations